Fundraising FoxPetra Pharma
New York, US · Founded 2015 · Delaware corporation · 6 known investors
Find your way into Petra Pharma
Sign up to see every warm intro you have to Petra Pharma
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Petra Pharma team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
BO
Brian O'CallaghanExecutive
DR
David RenasExecutive
AY
Albert YuNamed on SEC filing
DM
David McElligottNamed on SEC filing
Board
SG
JM
BD
Barbara DaltonBoard director
MJ
M. Johnston ErwinBoard director
TL
Thong LeBoard director
PS
Paul SekhriBoard director
Investors · 6
Pfizer Venture Investmentslisted by Pfizer Venture Investments$5M – $20M
How we know: Pfizer Venture Investments's portfolio page · funding news · Not right? Tell us
180 Degree CapitalreportedMenlo Park
How we know: funding news · Not right? Tell us
AbbViereportedCambridge · $300K – $3M
How we know: funding news · Not right? Tell us
AlexandriareportedPasadena
How we know: funding news · Not right? Tell us
ARCH Venture PartnersreportedChicago · $50K – $250M
How we know: funding news · Not right? Tell us
Johnson & Johnson Innovation – JJDCreportedNew Brunswick
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$58.8M disclosed across 2 rounds · 2015–2018
▶$27.5MraisedMar 2020 · 10 investors · BiotechnologyRule 506(b)
▶$27.5MraisedMar 2020 · 10 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Steve GillisDirector
- M. Johnston ErwinDirector
- Barbara DaltonDirector
- Jenna FogerDirector
- Paul SekhriDirector
- Thong LeDirector, Promoter
- David McElligottExecutive Officer, Promoter
- David RenasExecutive Officer
- Albert YuExecutive Officer
- Lindsay RaylePromoter
- David SchubertPromoter
- Brian O'CallaghanExecutive Officer, Director
- Offering amount
- $27.5M
- Amount sold
- $27.5M
- First sale
- Aug 2018
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$31.2MraisedJan 2018 · 13 investors · BiotechnologyRule 506(b)
▶$31.2MraisedJan 2018 · 13 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Lindsay RaylePromoter
- Paul SekhriDirector
- David SchubertPromoter
- Steve GillisDirector
- Joel MarcusDirector
- Barbara DaltonDirector
- Brian O'CallaghanExecutive Officer, Director
- M. Johnston ErwinDirector
- David RenasExecutive Officer
- Albert YuExecutive Officer, Promoter
- David McElligottExecutive Officer, Promoter
- Thong LeDirector, Promoter
- Offering amount
- $48.3M
- Amount sold
- $31.2M
- First sale
- Dec 2015
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Petra Pharma's investors?
- Petra Pharma's investors include Pfizer Venture Investments, 180 Degree Capital, AbbVie, Alexandria, ARCH Venture Partners, Johnson & Johnson Innovation – JJDC.
- How much funding has Petra Pharma raised?
- Petra Pharma has disclosed $58.8M raised across 2 rounds.
- Where is Petra Pharma headquartered?
- Petra Pharma is headquartered in New York, US.